Please use this identifier to cite or link to this item:
|Title:||Direct antiviral effect of cycloferon (10-carboxymethyl-9-acridanone) against adenovirus type 6 in vitro||Authors:||Slita, A V
Krivitskaya, V Z
Sirotkin, A K
Kovalenko, A L
Chatterjee, N K
Zarubaev, Vladimir V.
|Issue Date:||Apr-2003||Publisher:||Elsevier Masson||Journal:||Antiviral Research||Abstract:||Adenoviruses represent a broad group of human pathogens that currently have no specific and safe drugs for treatment. We demonstrated direct (non IFN-mediated) antiviral activity of cycloferon (10-carboxymethyl-9-acridanone, CMA), a potent interferon inducer, against adenovirus type 6 (Ad6) in Hep-2 cells. Virus production and details of morphogenesis were studied by ELISA with antibodies to the Ad6 hexon protein, and transmission electron microscopy, respectively. Immunoenzyme assay revealed that CMA does not inhibit viral protein synthesis but instead strongly reduces the ability of the virus to generate infectious progeny virus in a dose dependent manner. Ultrastructural study shows that CMA alters the structure of intranuclear virus-specific inclusions. We suggest that CMA suppresses the late stages of viral cycle in the infected cell.||URI:||https://cris.pasteurorg.ru/handle/123456789/177||ISSN:||0166-3542|
|Appears in Collections:||Journal articles|
Show full item record
checked on May 14, 2019
checked on May 20, 2019
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.